Back in 1992, the FDA's top brass turned to their own scientists to confirm suspicions that a popular allergy drug might cause heart problems. They pulled the drug from the market when tests proved the danger. But when similar concerns about Vioxx came up eight years later, the FDA dragged its feet. The
New York Times has analysis of how the FDA changed over the years, cozying up to the drug companies at the insistence of the White House and Congress.
(NYT)
No comments:
Post a Comment